Announced financings: March 7, 2024

Here's your roundup of yesterday's announced financings, courtesy of PrivatePlacements.com, the only platform that posts every Canadian financing, every day.

1. Mind Medicine Inc. (NEO: MMED)

• Gross Proceeds: $100 million; $75 million
• Sector: Biopharmaceuticals
• Units issued: 16.67 million; 12.5 million
• Type: Common shares
• Price: $6.00
• Warrants: None
• Agents: RBC Capital Markets; Non-brokered
• Use of Proceeds: Working capital

Company breakdown:

• Clinical-stage biopharmaceutical company developing products to treat brain health disorders
• Shares recently took off in anticipation of its MM120 treatment for generalized anxiety disorder receiving breakthrough therapy designation from the US FDA
• MM120 uses lysergide, a synthetic psychedelic